Gender-related differential item functioning in DSM-IV/DSM-5-III (alternative model) diagnostic criteria for borderline personality disorder.

2017 ◽  
Vol 8 (1) ◽  
pp. 87-93 ◽  
Author(s):  
Kathryn T. Benson ◽  
M. Brent Donnellan ◽  
Leslie C. Morey
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Differential Item Functioning ◽  
Diagnostic Criteria ◽  
Alternative Model ◽  
Borderline Personality ◽  
Dsm 5 ◽  
Item Functioning ◽  
Model Diagnostic ◽  
Dsm Iv

Interdiagnostician Reliability of the DSM-5 Section II and Section III Alternative Model Criteria for Borderline Personality Disorder

2019 ◽  
Vol 33 (6) ◽  
pp. 721-S18 ◽  
Author(s):  
Leslie C. Morey
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Mental Health Professionals ◽  
Alternative Model ◽  
Intraclass Correlation ◽  
National Sample ◽  
Borderline Personality ◽  
Diagnostic Reliability ◽  
Dsm 5 ◽  
Dsm Iv

This study examined the interdiagnostician reliability and potential gender bias of the DSM-IV/DSM-5 Section II and DSM-5 Alternative Model definitions of borderline personality disorder. A national sample of 123 mental health professionals provided diagnostic judgments on 12 case vignettes selected to represent a range of personality pathology. Two versions of each case were included, one identified as male and the other as female, but which were otherwise identical. Analyses examined the intraclass correlation between clinicians and also examined rates of diagnostic assignments as a function of case gender. Reliability of diagnosis of borderline personality did not differ across the two diagnostic approaches, and concordance of diagnoses across the two systems was significant. The dimensional components of the DSM-5 Alternative Model demonstrated significantly more diagnostic reliability than the DSM-IV categorical diagnoses. The DSM-5 Alternative Model conceptualization of borderline personality can be diagnosed with comparable or greater reliability than the extant DSM-IV definition.

Utility of DSM-5 section III personality traits in differentiating borderline personality disorder from comparison groups

2016 ◽  
Vol 37 ◽  
pp. 22-27 ◽  
Author(s):  
B. Bach ◽  
M. Sellbom ◽  
S. Bo ◽  
E. Simonsen
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Multinomial Logistic Regression ◽  
Borderline Personality ◽  
Healthy Controls ◽  
Emotional Lability ◽  
Dsm 5 ◽  
Comparison Groups ◽  
Dsm Iv ◽  
Matched Samples

AbstractObjectiveBorderline Personality Disorder (BPD) is a highly prevalent diagnosis in mental health care and includes a heterogeneous constellation of symptoms. As the field of personality disorder (PD) research moves to emphasize dimensional traits in its operationalization, it is important to determine how the alternative DSM-5 Section III personality trait dimensions differentiates such features in BPD patients versus comparison groups. To date, no study has attempted such validation.MethodThe current study examined the utility of the DSM-5 trait dimensions in differentiating patients with the categorical DSM-IV/5 diagnosis of BPD (n = 101) from systematically matched samples of other PD patients (n = 101) and healthy controls (n = 101). This was investigated using one-way ANOVA and multinomial logistic regression analyses.ResultsResults indicated that Emotional Lability, Risk Taking, and Suspiciousness uniquely differentiated BPD patients from other PD patients, whereas Emotional Lability, Depressivity, and Suspiciousness uniquely differentiated BPD patients from healthy controls.ConclusionEmotional Lability is in particular a key BPD feature of the proposed Section III model, whereas Suspiciousness also augments essential BPD features. Provided that these findings are replicated cross-culturally in forthcoming research, a more parsimonious traits operationalization of BPD features is warranted.

Convergence between DSM-5 Section II and Section III diagnostic criteria for borderline personality disorder

2013 ◽  
Vol 48 (4) ◽  
pp. 325-332 ◽  
Author(s):  
Martin Sellbom ◽  
Randy A Sansone ◽  
Douglas A Songer ◽  
Jaime L Anderson
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Diagnostic Criteria ◽  
Borderline Personality ◽  
Dsm 5

Clinical utility of the DSM-5 alternative model for borderline personality disorder: Differential diagnostic accuracy of the BFI, SCID-II-PQ, and PID-5

2018 ◽  
Vol 80 ◽  
pp. 97-103 ◽  
Author(s):  
J. Christopher Fowler ◽  
Alok Madan ◽  
Jon G. Allen ◽  
Michelle Patriquin ◽  
Carla Sharp ◽  
...  
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Diagnostic Accuracy ◽  
Alternative Model ◽  
Clinical Utility ◽  
Borderline Personality ◽  
Dsm 5

scholarly journals Can DSM-IV borderline personality disorder be diagnosed via dimensional personality traits? Implications for the DSM-5 personality disorder proposal.

2012 ◽  
Vol 121 (4) ◽  
pp. 944-950 ◽  
Author(s):  
Joshua D. Miller ◽  
Jennifer Q. Morse ◽  
Kimberly Nolf ◽  
Stephanie D. Stepp ◽  
Paul A. Pilkonis
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Personality Traits ◽  
Borderline Personality ◽  
Dsm 5 ◽  
Dsm Iv

scholarly journals Bordering on the bipolar: a review of criteria for ICD-11 and DSM-5 persistent mood disorders

2019 ◽  
Vol 26 (1) ◽  
pp. 50-57 ◽  
Author(s):  
Jason Luty
Keyword(s):  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Mood Disorders ◽  
Diagnostic Criteria ◽  
Borderline Personality ◽  
List Type ◽  
Emotional Experiences ◽  
Bipolar Ii Disorder ◽  
Dsm 5 ◽  
Bipolar Ii

SUMMARYThe principal manuals for psychiatric diagnosis have recently been updated (ICD-11 was released in June 2018 and DSM-5 was published in 2013). A common diagnostic quandary is the classification of people with chronic low mood, especially those with repeated self-harm (‘emotionally unstable’ or ‘borderline’ personality disorder). There has been a great interest in use of type II bipolar affective disorder (‘bipolar II disorder’) as a less pejorative diagnostic alternative to ‘personality disorder’, despite the radically different treatment options for these disorders. DSM-5 (but not ICD-11) clearly distinguishes between borderline personality disorder and bipolar II disorder, indicating that intense emotional experiences (such as anger, panic or despair; irritability; anxiety) should persist for only a few hours in people with a personality disorder. Both manuals now use the term ‘borderline personality disorder’ rather than ‘emotionally unstable personality disorder’. The diagnostic criteria for cyclothymic disorder remain confusing.LEARNING OBJECTIVESAfter reading this article you will be able to: •appreciate the key differences in diagnostic classification between persistent mood disorders: bipolar II disorder, borderline personality disorder and dysthymia•be aware of the modest differences between ICD-10, ICD-11 and DSM-5 in diagnostic criteria for these disorders•appreciate that intense emotional experiences need persist for only a few hours to meet criteria for DSM-5 borderline personality disorder and that persistent emotional dysregulation (e.g. irritability, impulsiveness, disinhibition) for a few days meets criteria for DSM-5 bipolar II disorder.

Comparison of Three Questionnaires to Screen for Borderline Personality Disorder in Adolescents and Young Adults

2017 ◽  
Vol 33 (2) ◽  
pp. 123-128 ◽  
Author(s):  
Anne van Alebeek ◽  
Paul T. van der Heijden ◽  
Christel Hessels ◽  
Melissa S.Y. Thong ◽  
Marcel van Aken
Keyword(s):  
Young Adults ◽  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Borderline Personality ◽  
Adolescents And Young Adults ◽  
Patient Questionnaire ◽  
Statistical Manual ◽  
Axis Ii ◽  
Diagnostic And Statistical Manual ◽  
Dsm Iv

Abstract. One of the most common personality disorders among adolescents and young adults is the Borderline Personality Disorder (BPD). The objective of current study was to assess three questionnaires that can reliably screen for BPD in adolescents and young adults (N = 53): the McLean Screening Instrument for BPD (MSI-BPD; Zanarini et al., 2003 ), the Personality Diagnostic Questionnaire 4th edition – BPD scale (PDQ-4 BPD; Hyler, 1994 ), and the SCID-II Patient Questionnaire – BPD scale (SCID-II-PQ BPD). The nine criteria of BPD according to the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV; APA, 1994 ) were measured with the Structural Clinical Interview for DSM-IV Axis II disorders – BPD scale (SCID-II; First, Spitzer, Gibbon, Williams, & Benjamin, 1995 ). Correlations between the questionnaires and the SCID-II were calculated. In addition, the sensitivity and specificity of the questionnaires were tested. All instruments predicted the BPD diagnosis equally well.

scholarly journals Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Silvio Bellino ◽  
Paola Bozzatello ◽  
Camilla Rinaldi ◽  
Filippo Bogetto
Keyword(s):  
Borderline Personality Disorder ◽  
Pilot Study ◽  
Personality Disorder ◽  
Adverse Events ◽  
Mechanism Of Action ◽  
Severity Index ◽  
Borderline Personality ◽  
Controlled Trials ◽  
Efficacy And Safety ◽  
Dsm Iv

Antipsychotics are recommended for the treatment of impulsive dyscontrol and cognitive perceptual symptoms of borderline personality disorder (BPD). Three reports supported the efficacy of oral risperidone on BPD psychopathology. Paliperidone ER is the metabolite of risperidone with a similar mechanism of action, and its osmotic release reduces plasmatic fluctuations and antidopaminergic effects. The aim of this study is to evaluate efficacy and safety of paliperidone ER in BPD patients. 18 outpatients with a DSM-IV-TR diagnosis of BPD were treated for 12 weeks with paliperidone ER (3–6 mg/day). They were assessed at baseline, week 4, and week 12, using the CGI-Severity item, the BPRS, the HDRS, the HARS, the SOFAS, the BPD Severity Index (BPDSI), and the Barratt Impulsiveness Scale (BIS-11). Adverse events were evaluated with the DOTES. Paliperidone ER was shown to be effective and well tolerated in reducing severity of global symptomatology and specific BPD symptoms, such as impulsive dyscontrol, anger, and cognitive-perceptual disturbances. Results need to be replicated in controlled trials.

Sign in / Sign up

Export Citation Format

Share Document